- Home
- MYGN vs OTLY Comparison
MYGN vs OTLY Comparison
Compare MYGN & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- OTLY
- Stock Information
- Founded
- MYGN 1991
- OTLY 1994
- Country
- MYGN United States
- OTLY Sweden
- Employees
- MYGN N/A
- OTLY N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- OTLY Packaged Foods
- Sector
- MYGN Health Care
- OTLY Consumer Staples
- Exchange
- MYGN Nasdaq
- OTLY Nasdaq
- Market Cap
- MYGN 642.0M
- OTLY 518.0M
- IPO Year
- MYGN 1995
- OTLY 2021
- Fundamental
- Price
- MYGN $8.33
- OTLY $15.69
- Analyst Decision
- MYGN Hold
- OTLY Buy
- Analyst Count
- MYGN 13
- OTLY 5
- Target Price
- MYGN $13.50
- OTLY $19.25
- AVG Volume (30 Days)
- MYGN 959.5K
- OTLY 118.9K
- Earning Date
- MYGN 11-04-2025
- OTLY 10-29-2025
- Dividend Yield
- MYGN N/A
- OTLY N/A
- EPS Growth
- MYGN N/A
- OTLY N/A
- EPS
- MYGN N/A
- OTLY N/A
- Revenue
- MYGN $832,900,000.00
- OTLY $828,200,000.00
- Revenue This Year
- MYGN $0.06
- OTLY $3.73
- Revenue Next Year
- MYGN $5.68
- OTLY $4.71
- P/E Ratio
- MYGN N/A
- OTLY N/A
- Revenue Growth
- MYGN 3.83
- OTLY 4.43
- 52 Week Low
- MYGN $3.76
- OTLY $6.00
- 52 Week High
- MYGN $22.92
- OTLY $19.13
- Technical
- Relative Strength Index (RSI)
- MYGN 64.16
- OTLY 52.78
- Support Level
- MYGN $7.68
- OTLY $14.66
- Resistance Level
- MYGN $8.25
- OTLY $16.42
- Average True Range (ATR)
- MYGN 0.38
- OTLY 0.88
- MACD
- MYGN -0.01
- OTLY 0.25
- Stochastic Oscillator
- MYGN 78.80
- OTLY 76.04
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About OTLY Oatly Group AB
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.